Department of Chemistry and Biochemistry, University of Arizona, 1306 East University Boulevard, Tucson, Arizona 85721, USA.
J Am Chem Soc. 2010 Aug 25;132(33):11727-35. doi: 10.1021/ja104491h.
The 518 protein kinases encoded in the human genome are exquisitely regulated and their aberrant function(s) are often associated with human disease. Thus, in order to advance therapeutics and to probe signal transduction cascades, there is considerable interest in the development of inhibitors that can selectively target protein kinases. However, identifying specific compounds against such a large array of protein kinases is difficult to routinely achieve utilizing traditional activity assays, where purified protein kinases are necessary. Toward a simple, rapid, and practical method for identifying specific inhibitors, we describe the development and application of a split-protein methodology utilizing a coiled-coil-assisted three-hybrid system. In this approach, a protein kinase of interest is attached to the C-terminal fragment of split-firefly luciferase and the coiled-coil Fos, which is specific for the coiled-coil Jun, is attached to the N-terminal fragment. Upon addition of Jun conjugated to a pan-kinase inhibitor such as staurosporine, a three-hybrid complex is established with concomitant reassembly of the split-luciferase enzyme. An inhibitor can be potentially identified by the commensurate loss in split-luciferase activity by displacement of the modified staurosporine. We demonstrate that this new three-hybrid approach is potentially general by testing protein kinases from the different kinase families. To interrogate whether this method allows for screening inhibitors, we tested six different protein kinases against a library of 80 known protein kinase inhibitors. Finally, we demonstrate that this three-hybrid system can potentially provide a rapid method for structure/function analysis as well as aid in the identification of allosteric inhibitors.
人类基因组中编码的 518 种蛋白激酶受到精细调控,其功能异常通常与人类疾病有关。因此,为了推进治疗方法并探究信号转导级联,人们对开发能够选择性靶向蛋白激酶的抑制剂产生了浓厚的兴趣。然而,利用传统的活性测定法,即需要纯化蛋白激酶,来识别针对如此庞大的蛋白激酶阵列的特定化合物是很困难的。为了寻找一种简单、快速且实用的方法来识别特定抑制剂,我们描述了一种利用卷曲螺旋辅助三杂交系统的分裂蛋白方法的开发和应用。在这种方法中,感兴趣的蛋白激酶与分裂萤火虫荧光素酶的 C 端片段相连,而特异性针对卷曲螺旋 Jun 的卷曲螺旋 Fos 与 N 端片段相连。加入与泛激酶抑制剂如星形孢菌素结合的 Jun 后,会形成三杂交复合物,并伴随着分裂荧光素酶的重新组装。通过置换修饰后的星形孢菌素,潜在抑制剂可以通过相应的分裂荧光素酶活性丧失来鉴定。我们通过测试来自不同激酶家族的蛋白激酶,证明了这种新的三杂交方法具有通用性。为了探究这种方法是否允许筛选抑制剂,我们用 80 种已知的蛋白激酶抑制剂文库对六种不同的蛋白激酶进行了测试。最后,我们证明这种三杂交系统有可能为结构/功能分析提供一种快速方法,并有助于鉴定别构抑制剂。